Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Dhellin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The EMBO Journal|November 14, 1997
Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcriptionO Dhellin, J Maestre, T Heidmann
The EMBO Journal|December 15, 1995
mRNA retroposition in human cells: processed pseudogene formationJ Maestre, T Tchénio, O Dhellin, et al.
Nucleic Acids Research|April 25, 1994
Retrotransposition of a marked Drosophila line-like I element in cells in cultureS Jensen, L Cavarec, O Dhellin, et al.
Clinical and Experimental Immunology|March 14, 2013
Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levelsL Semerano, J Biton, L Delavallée, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The EMBO Journal|November 14, 1997
Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcriptionO Dhellin, J Maestre, T Heidmann
The EMBO Journal|December 15, 1995
mRNA retroposition in human cells: processed pseudogene formationJ Maestre, T Tchénio, O Dhellin, et al.
Nucleic Acids Research|April 25, 1994
Retrotransposition of a marked Drosophila line-like I element in cells in cultureS Jensen, L Cavarec, O Dhellin, et al.
Clinical and Experimental Immunology|March 14, 2013
Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levelsL Semerano, J Biton, L Delavallée, et al.
Pageof 1